Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Brilliance iCT and Brilliance iCT SP These systems are intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data taken at different angles and planes. May include signal analysis and display equipment, patient and equipment supports, components and accessories

FDA Recall Z-0831-2014 · Posted 2014-01-27

Recalling FirmPhilips Medical Systems (Cleveland) Inc
Recall StatusTerminated
Product CodeJAK
Date Initiated2013-07-16
Date Terminated2014-09-19
Product Quantity506

Reason for Recall

An artifact that resembles thrombus may appear on the image.

Firm Action

Philips sent an Field Safety Notice dated July 15, 2013, to all US customers via certified mail. Market representatives will distribute the letter internationally. The letter identified the product the problem and the action needed to be taken by the customers. Additionally, a Field Service Engineer will contact each site to schedule a time to implement the Field Change Order. If you need any further information or support concerning this issue, please contact your local Philips representative or local Philips Healthcare office.For North America and Canada, contact the Customer Care Solutions Center (1"800-722"9377,Option 5: Enter Site 10 or follow the prompts). This notice has been reported to the appropriate Regulatory Agency Philips apologizes for any inconveniences caused by this problem

Root Cause

Device Design

Distribution Pattern

Worldwide Distribution - USA (nationwide) including Puerto Rico and the states AL, AR, AZ, CA, DC, DE, FL, GA, IA, IL, IN, KY, MA, MD, MN, MO, MS, NC, NV, NY, OH, OK, OR, PA, SC, TX, VT, WA, and WV., and the countries of Argentina, Australia, Austria, Azerbaijan, Bangladesh, Belgium, Brazil, Chile, China, Czech Republic, Denmark, Egypt, France, Germany, Greece, Hungary, Iceland, India, Indonesia, Iraq, Ireland, Israel, Italy, Japan, Jordan, Lebanon, Netherlands, New Zealand, Norway, Oman, Panama, Philippines, Poland, Qatar, Romania, Russia, Saudi Arabia, Singapore, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Arab Emirates, United Kingdom, and Uzbekistan.

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

K060937BRILLIANCE VOLUMEPhilips Medical Systems (Cleveland), Inc. · 2006-06-05

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑